CUBIST PHARMACEUTICALS INC Research and Development Expense
CUBIST PHARMACEUTICALS INC reported Research and Development Expense of $66.03 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-11-07
- CUBIST PHARMACEUTICALS INC research and development expense for the quarter ending 2014-09-30 was $66.03M, a 46.50% decline year-over-year.
- CUBIST PHARMACEUTICALS INC research and development expense for the quarter ending 2014-06-30 was $104.86M, a 8.97% decline year-over-year.
- CUBIST PHARMACEUTICALS INC research and development expense for the quarter ending 2014-03-31 was $120.60M, a 5.60% increase year-over-year.
- CUBIST PHARMACEUTICALS INC research and development expense for the quarter ending 2013-12-31 was $124.92M, a 40.11% increase year-over-year.
- CUBIST PHARMACEUTICALS INC research and development expense for fiscal 2013 was $477.74M, a 72.02% increase from fiscal 2012.
- CUBIST PHARMACEUTICALS INC research and development expense for fiscal 2012 was $277.73M, a 50.50% increase from fiscal 2011.
- CUBIST PHARMACEUTICALS INC research and development expense for fiscal 2011 was $184.53M, a 16.90% increase from fiscal 2010.
- CUBIST PHARMACEUTICALS INC research and development expense for fiscal 2010 was $157.85M, a 7.46% decline from fiscal 2009.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2014-09-30 | $66.03M 10-Q · filed 2014-11-07 | $170.89M derived: sum of 2 quarters · filed 2014-11-07 | $291.50M 10-Q · filed 2014-11-07 | $416.42M derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | $104.86M 10-Q · filed 2014-08-11 | $225.47M 10-Q · filed 2014-08-11 | $350.38M derived: sum of 3 quarters · filed 2014-08-11 | $473.81M derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-03-31 | $120.60M 10-Q · filed 2014-05-02 | $245.52M derived: sum of 2 quarters · filed 2014-05-02 | $368.94M derived: sum of 3 quarters · filed 2014-11-07 | $484.13M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-12-31 | $124.92M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $248.34M derived: sum of 2 quarters · filed 2014-11-07 | $363.53M derived: sum of 3 quarters · filed 2014-11-07 | $477.74M 10-K · filed 2014-02-25 |
| 2013-09-30 | $123.42M 10-Q · filed 2014-11-07 | $238.61M derived: sum of 2 quarters · filed 2014-11-07 | $352.82M 10-Q · filed 2014-11-07 | $441.98M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $115.19M 10-Q · filed 2014-08-11 | $229.40M 10-Q · filed 2014-08-11 | $318.55M derived: sum of 3 quarters · filed 2014-08-11 | $388.75M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | $114.21M 10-Q · filed 2014-05-02 | $203.36M derived: sum of 2 quarters · filed 2014-05-02 | $273.56M derived: sum of 3 quarters · filed 2014-05-02 | $340.77M derived: sum of 4 quarters · filed 2014-05-02 |
| 2012-12-31 | $89.15M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $159.35M derived: sum of 2 quarters · filed 2014-02-25 | $226.56M derived: sum of 3 quarters · filed 2014-02-25 | $277.73M 10-K · filed 2014-02-25 |
| 2012-09-30 | $70.20M 10-Q · filed 2013-11-12 | $137.40M derived: sum of 2 quarters · filed 2013-11-12 | $188.57M 10-Q · filed 2013-11-12 | $244.65M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $67.21M 10-Q · filed 2013-08-06 | $118.38M 10-Q · filed 2013-08-06 | $174.45M derived: sum of 3 quarters · filed 2014-02-25 | $220.62M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $51.17M 10-Q · filed 2013-05-07 | $107.25M derived: sum of 2 quarters · filed 2014-02-25 | $153.42M derived: sum of 3 quarters · filed 2014-02-25 | $195.29M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $56.08M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $102.25M derived: sum of 2 quarters · filed 2014-02-25 | $144.12M derived: sum of 3 quarters · filed 2014-02-25 | $184.53M 10-K · filed 2014-02-25 |
| 2011-09-30 | $46.17M 10-Q · filed 2012-11-05 | $88.04M derived: sum of 2 quarters · filed 2012-11-05 | $128.46M 10-Q · filed 2012-11-05 | $170.33M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $41.87M 10-Q · filed 2012-08-07 | $82.29M 10-Q · filed 2012-08-07 | $124.16M derived: sum of 3 quarters · filed 2013-02-27 | $161.11M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $40.42M 10-Q · filed 2012-05-01 | $82.29M derived: sum of 2 quarters · filed 2013-02-27 | $119.24M derived: sum of 3 quarters · filed 2013-02-27 | $159.39M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $41.87M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $78.83M derived: sum of 2 quarters · filed 2013-02-27 | $118.97M derived: sum of 3 quarters · filed 2013-02-27 | $157.85M 10-K · filed 2013-02-27 |
| 2010-09-30 | $36.95M 10-Q · filed 2011-11-02 | $77.10M derived: sum of 2 quarters · filed 2011-11-02 | $115.98M 10-Q · filed 2011-11-02 | $168.12M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $40.15M 10-Q · filed 2011-07-29 | $79.03M 10-Q · filed 2011-07-29 | $131.16M derived: sum of 3 quarters · filed 2012-02-27 | $166.69M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $38.88M 10-Q · filed 2011-04-29 | $91.02M derived: sum of 2 quarters · filed 2012-02-27 | $126.54M derived: sum of 3 quarters · filed 2012-02-27 | $158.91M derived: sum of 4 quarters · filed 2012-02-27 |
| 2009-12-31 | $52.13M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $87.66M derived: sum of 2 quarters · filed 2012-02-27 | $120.03M derived: sum of 3 quarters · filed 2012-02-27 | $170.57M 10-K · filed 2012-02-27 |
| 2009-09-30 | $35.53M 10-Q · filed 2010-10-29 | $67.90M derived: sum of 2 quarters · filed 2010-10-29 | $118.44M 10-Q · filed 2010-10-29 | |
| 2009-06-30 | $32.37M 10-Q · filed 2010-07-30 | $82.91M 10-Q · filed 2010-07-30 | ||
| 2008-12-31 | $126.67M 10-K · filed 2011-02-23 |